Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 iOncologi Acquires TargImmune Therapeutics | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

iOncologi Acquires TargImmune Therapeutics

This deal will expand and strengthen iOncologi’s immunotherapy pipeline against solid tumors.

By: Rachel Klemovitch

Assistant Editor

iOncologi, Inc., a clinical-stage biopharmaceutical company, announced the acquisition of TargImmune Therapeutics, a biotechnology company specializing in novel tumor-targeted immunotherapies. This strategic acquisition significantly enhances iOncologi’s capabilities in developing immunotherapies for solid tumors.

The acquisition aligns with iOncologi’s broader strategy to expand its therapeutic pipeline, leverage RNA-based immunotherapies, and drive innovation in oncology.

As part of the transaction, iOncologi, Inc. and TargImmune Therapeutics executed a share purchase agreement, resulting in iOncologi acquiring at least 99% of TargImmune’s shares, warrants, and options.

Following the acquisition, TargImmune will continue to operate in Basel, Switzerland, as a wholly owned subsidiary of iOncologi, Inc. This structure ensures the continuation of TargImmune’s research into tumor-targeted RNA therapies while benefiting from iOncologi’s resources and strategic vision.

“This acquisition represents a pivotal moment for iOncologi as we continue to push the boundaries of immunotherapy for solid tumors,” said Dr. Edgardo Rodriguez-Lebron, iOncologi’s recently appointed CEO. “TargImmune’s pioneering approaches perfectly align with our mission to develop transformative cancer therapies.”

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters